Evidence map›Paper›PMID 23714204›Full record

ArticleVirology journal2013

Whole genome sequencing and comparative genomic analyses of two Vibrio cholerae O139 Bengal-specific Podoviruses to other N4-like phages reveal extensive genetic diversity.

Derrick E Fouts, Jochen Klumpp, Kimberly A Bishop-Lilly, Mathumathi Rajavel, Kristin M Willner, Amy Butani, Matthew Henry, Biswajit Biswas, Manrong Li, M John Albert and 3 more

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Screening of PotentialFrontiers in microbiology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Viruses · 2018
    Article
  12. Novel N4-Like Bacteriophages of Pectobacterium atrosepticum.Pharmaceuticals (Basel, Switzerland) · 2018
    Article
  13. Comparison ofAntibiotics (Basel, Switzerland) · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Novel N4 Bacteriophages Prevail in the Cold Biosphere.Applied and environmental microbiology · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 3 countries.

Derrick E FoutsJ Craig Venter Institute, Rockville, MD, USA.
Jochen Klumpp
Kimberly A Bishop-Lilly
Mathumathi Rajavel
Kristin M Willner
Amy Butani
Matthew Henry
Biswajit Biswas
Manrong Li
M John Albert
Martin J Loessner
Richard Calendar
Shanmuga Sozhamannan
Naval Medical Research Command · USETH Zurich · CHJackson Foundation · USHenry M. Jackson Foundation · USIntralytix (United States) · USJ. Craig Venter Institute · USKuwait University · KWMorgan State University · USUniversity of California, Berkeley · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVibrio cholerae O139 Bengal is the only serogroup other than O1 implicated in cholera epidemics. We describe the isolation and characterization of an O139 serogroup-specific phage, vB_VchP_VchO139-I (ϕVchO139-I) that has similar host range and virion morphology as phage vB_VchP_JA1 (ϕJA1) described previously. We aimed at a complete molecular characterization of both phages and elucidation of their genetic and structural differences and assessment of their genetic relatedness to the N4-like phage group.

methodsHost-range analysis and plaque morphology screening were done for both ϕJA1 and ϕVchO139-I. Both phage genomes were sequenced by a 454 and Sanger hybrid approach. Genomes were annotated and protein homologies were determined by Blast and HHPred. Restriction profiles, PFGE patterns and data on the physical genome structure were acquired and phylogenetic analyses were performed.

resultsThe host specificity of ϕJA1 has been attributed to the unique capsular O-antigen produced by O139 strains. Plaque morphologies of the two phages were different; ϕVchO139-I produced a larger halo around the plaques than ϕJA1. Restriction profiles of ϕJA1 and ϕVchO139-I genomes were also different. The genomes of ϕJA1 and ϕVchO139-I consisted of linear double-stranded DNA of 71,252 and 70,938 base pairs. The presence of direct terminal repeats of around 1974 base pairs was demonstrated. Whole genome comparison revealed single nucleotide polymorphisms, small insertions/deletions and differences in gene content. Both genomes had 79 predicted protein encoding sequences, of which only 59 were identical between the two closely related phages. They also encoded one tRNA-Arg gene, an intein within the large terminase gene, and four homing endonuclease genes. Whole genome phylogenetic analyses of ϕJA1 and ϕVchO139-I against other sequenced N4-like phages delineate three novel subgroups or clades within this phage family.

conclusionsThe closely related phages feature significant genetic differences, in spite of being morphologically identical. The phage morphology, genetic organization, genomic content and large terminase protein based phylogeny support the placement of these two phages in the Podoviridae family, more specifically within the N4-like phage group. The physical genome structure of ϕJA1 could be demonstrated experimentally. Our data pave the way for potential use of ϕJA1 and ϕVchO139-I in Vibrio cholerae typing and control.

Indexed as

Genetic VariationGenome, ViralCluster AnalysisDNA, ViralHost SpecificityHumansMolecular Sequence DataPhylogenyPodoviridaeSequence Analysis, DNAVibrio cholerae O139Viral Plaque AssayDNA, Viral

Identifiers

PMID23714204
PMCPMC3670811
OpenAlexW2114181928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.